Correlation between enzymatic estimation of infarct size and early mortality rate. 1983

J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström

In 585 patients with a first acute myocardial infarction the maximum activity of heat stable lactate dehydrogenase (EC 1.1.1.27) was correlated with mortality at three months. The patients participated in a double blind trial with metoprolol in acute myocardial infarction. In all patients not taking a beta blocker a highly significant correlation was found, but this was not evident in those who were. When patients with anterior or inferior infarctions treated with a placebo were analysed separately the correlation remained, as it did when the patients who were alive on the fourth day after the onset of pain were analysed separately. No correlation was observed between enzyme activity and three month mortality in these subgroups if only patients treated with metoprolol were included. In a subsample of only 171 patients it was found that the maximum activity of creatine kinase (EC 2.7.3.2) and creatine kinase subunit B did not correlate with three month mortality regardless of treatment. Thus it is concluded that when a sufficiently large number of patients are investigated there is a highly significant correlation between the enzymatic estimation of infarct size and early mortality in acute myocardial infarction. This relation did not persist when patients treated with beta blockade were analysed.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
August 1983, Circulation,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
July 1975, Circulation,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
November 1975, Circulation,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
May 1983, The American journal of cardiology,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
January 1988, Cardiologia (Rome, Italy),
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
October 1977, Circulation,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
December 2013, JACC. Cardiovascular interventions,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
January 1976, Recent advances in studies on cardiac structure and metabolism,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
March 1972, Health services reports,
J Herlitz, and A Hjalmarson, and J Waldenström, and K Swedberg, and F Waagstein, and A Waldenström
January 1989, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!